NephroPlus implements provider-driven strategy to combat Hepatitis C in treating Haemodialysis… In a pilot study conducted from 2022 to 2024, NephroPlus screened maintenance haemodialysis patients for Hepatitis C across 11…
IIIT Delhi develops AI model for drug repositioning in treatment of COVID-19 This means that instead of manually going through available drugs, checking its effectiveness against COVID-19, AI can speed…